fashion -WSS

fashion

author：comprehensive 2025-09-06 02:04:51 - browse：5447

Person wearing a blue glove holding money against a blue backdrop. — Adobe

WASHINGTON — Medicare officials are moving forward with a plan to claw back money from certain hospitals to try to remedy overpayments struck down by the Supreme Court, they announced Thursday.

A federal court ordered the Department of Health and Human Services to compensate hospitals that receive discounted drugs through the 340B program for billions of dollars of underpayments, but the money had already gone out to hospitals that didn’t participate in the program.

Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in the drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Why Novartis is going to walk from its acquisition of MorphoSys

leisure time

WSS

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Devoted Health’s losses in Medicare Advantage persist

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

More hospitals are billing patients as online messages surge

Gene therapy for Afghan refugees’ infant will be fully covered

The Biogen Aduhelm mess could happen again

focus

fashion

explore

Medicare details structure of new drug price negotiation program

US soldier in North Korean custody after crossing DMZ line

Guidelines to prevent youth baseball injuries need more muscle

AstraZeneca stays mum on Medicare drug pricing negotiations

Hepatitis C has a cure — but many Americans still lack access to it

Why CTE doesn’t keep Americans from enjoying the Super Bowl

New air purifier tech could be key to improving indoor air quality

Robert Kennedy Jr.'s presidential campaign attracts GOP

How to save PrEP access — and even expand it

Adopting new red light myopia treatments may be short

entertainment

AstraZeneca stays mum on Medicare drug pricing negotiations

Medicare Advantage plans can’t deny care with AI, CMS warns

Why Novartis is going to walk from its acquisition of MorphoSys

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Johnson & Johnson sues to stop Medicare negotiation

leisure time

hotspot

focus

hotspot